Physician-led care in Houston Heights
A personalized, laboratory-guided weight-management program with tirzepatide, built around your medical history, metabolic health, goals, and treatment response — delivered from our clinic on Houston Avenue, with mobile visits available across Greater Houston.
Non-member tirzepatide pricing starts at $400 per month; members receive preferred pricing. Consultation does not guarantee medication eligibility.
Your treatment pathway
Your treatment plan is developed through clinical evaluation rather than a one-size-fits-all protocol. Medication selection and eligibility remain subject to professional medical judgment by our Houston clinical team.
We begin with your health history, current medications, prior weight-management experience, goals, and relevant clinical concerns.
When treatment is clinically appropriate, your plan is selected and adjusted according to your individual needs.
Follow-up care helps evaluate response, tolerability, adverse effects, and the next appropriate clinical step. Select follow-up visits may be available through Aevum Mobile across Greater Houston.
Transparent non-member pricing
Final pricing and dosing depend on your individualized treatment plan, clinical needs, medication dose, and program participation. Pricing current as of August 2026.
Starting at
Starting at
Members receive preferred pricing on tirzepatide treatment and additional wellness benefits — compare Aevum membership tiers.
A higher dose is not automatically more effective or appropriate for an individual patient. Not every patient will advance to higher dosing. Results vary, and no specific outcome is guaranteed.
More than a prescription
Tirzepatide may support appetite regulation and weight management, but medication is only one component of care. Aevum combines individualized treatment with physician oversight, clinical monitoring, nutrition considerations, activity planning, and long-term strategy.
Tirzepatide acts on GIP and GLP-1 receptor pathways involved in appetite regulation and food intake.
Some patients experience fewer food cravings, which may make structured nutrition choices easier to maintain.
Feeling satisfied with smaller portions may help support a sustainable calorie deficit without extreme restriction.
Weight reduction may support broader cardiometabolic goals when combined with appropriate clinical care.
Tirzepatide affects pathways involved in glucose-dependent insulin signaling and blood-sugar regulation.
Care is structured around consistent progress, realistic expectations, and a long-term maintenance plan.
Nutrition, protein intake, and appropriate activity are considered to support lean mass during weight loss. Some patients also explore peptide therapy when clinically appropriate.
Improved health behaviors and gradual weight reduction may support mobility, confidence, and daily function. Energy and sleep concerns may also relate to hormone health.
Response, side effects, dosing, and clinical concerns are reviewed throughout the treatment process by our Houston clinical team.
Your plan is adjusted according to medical history, goals, laboratory findings, response, and tolerability.
Individual evaluation is required. Not every patient qualifies for medication, and no specific amount or rate of weight loss is guaranteed.
Discuss Your GoalsMedical weight-loss questions
Learn about physician-led tirzepatide treatment in Houston, medical monitoring, candidacy, realistic expectations, and the distinction between currently available care and investigational retatrutide research.
Tirzepatide activates GIP and GLP-1 receptor pathways involved in appetite regulation, satiety, food intake, and glucose-dependent insulin signaling. Individual response and tolerability vary, and treatment should be guided by a qualified clinician.
Potential candidacy depends on weight-related health concerns, medical history, current medications, prior treatment, goals, risks, and clinical judgment. Not every patient qualifies for medication, and an individualized evaluation is required.
Tirzepatide may not be appropriate for everyone. Your evaluation includes screening for personal or family history of medullary thyroid carcinoma or MEN 2, pancreatitis, severe gastrointestinal disease, pregnancy or plans to become pregnant, and certain medication interactions. Suitability is determined only through individualized clinical assessment with a qualified clinician.
Results vary widely according to dose, treatment duration, medical conditions, nutrition, activity, adherence, side effects, and individual biology. Aevum does not guarantee a particular number, percentage, or timeline for weight loss.
Some patients notice appetite or satiety changes early, while weight trends often develop gradually. Dose escalation is usually based on response and tolerability rather than a fixed promise of rapid results.
Potential effects may include nausea, diarrhea, constipation, vomiting, abdominal discomfort, reduced appetite, or other symptoms. Risks, warnings, medication interactions, and concerning symptoms should be reviewed during your clinical evaluation.
Your first visit is a consultation covering health history, current medications, prior weight-management experience, goals, and relevant clinical concerns. It includes contraindication and risk screening, discussion of laboratory assessment when appropriate, and a review of whether a currently available treatment option may be suitable. Scheduling a consultation does not guarantee medication eligibility.
Weight regain can occur after medication is reduced or stopped. Long-term planning may involve continued treatment when appropriate, nutrition and activity strategies, behavioral support, and a clinician-guided maintenance plan.
Laboratory testing may be recommended according to your medical history, symptoms, medications, risk factors, and clinical needs. Testing is individualized rather than automatically identical for every patient. You can read more about how lab-guided care works at Aevum.
Yes. Aevum's program is physician led under Medical Director Xinwei Liu, MD, and includes individualized evaluation, treatment planning, monitoring, and clinical decision-making. Other qualified clinicians may participate in care under the clinic's medical structure.
Aevum is a physician-led clinic in Houston Heights where treatment decisions are guided by individualized clinical evaluation and laboratory findings rather than a standard protocol. Care includes in-person access to the clinical team, ongoing response and tolerability monitoring, dose decisions based on clinical judgment, and long-term maintenance planning. Meet the clinical team.
Dose decisions are based on treatment response, side effects, tolerability, clinical goals, current health status, and professional judgment. A higher dose is not automatically more appropriate or more effective for every patient.
Treatment duration is individualized. Medical obesity treatment may require ongoing management, but continued therapy depends on effectiveness, safety, tolerability, goals, preferences, and the clinician's assessment.
No. Semaglutide acts at the GLP-1 receptor pathway, while tirzepatide acts at both GIP and GLP-1 receptor pathways. The most appropriate option depends on individual medical considerations and clinician judgment.
No. Medication may help support appetite regulation and adherence, but nutrition quality, adequate protein, activity, sleep, recovery, and long-term behavior remain important components of metabolic and body-composition health. Some patients also explore peptide therapy or hormone optimization as part of a broader plan when clinically appropriate.
Retatrutide is an investigational once-weekly molecule being studied for activity at GIP, GLP-1, and glucagon receptor pathways. Research is evaluating its potential effects on weight, glucose regulation, and broader cardiometabolic health.
No. As of July 26, 2026, retatrutide remains investigational and has not received FDA approval. Planned regulatory submissions or anticipated timelines are not the same as approval and may change.
No. Aevum Restorative Wellness does not offer, prescribe, sell, administer, source, reserve, or maintain a waitlist for retatrutide. The retatrutide information on this page is educational only.
Schedule a consultation through Aevum's online booking page, or call 713-280-1551. Your consultation gives the clinical team a chance to review your goals, history, and whether a currently available treatment option may be appropriate for you.
Ready to discuss a personalized, physician-led medical weight-loss plan in Houston?
Book Your ConsultationMembers receive preferred pricing on treatment plans — compare Aevum membership tiers. You can also explore all Aevum services or learn about mobile visits across Greater Houston.
Medically reviewed by Xinwei Liu, MD, Medical Director — July 26, 2026. This page is reviewed on an ongoing basis and is educational only; it does not replace individualized medical advice.
Investigational — Not Currently Available
Patients often ask about retatrutide, an investigational triple hormone receptor agonist being evaluated in advanced clinical trials. It is not FDA approved, and Aevum does not offer, prescribe, sell, administer, source, reserve, or maintain a waitlist for it.
Because the question comes up often, we maintain a separate educational review of the published and sponsor-reported research, including what remains unresolved.
Read our full review of retatrutide researchAevum currently provides consultation for available medical weight-management options, including physician-guided tirzepatide treatment. Booking a consultation is not a retatrutide reservation, enrollment, prescription request, or waitlist. Research findings are population averages and do not predict or guarantee an individual outcome. See our lab-guided approach or membership pricing.
Begin with a thoughtful clinical conversation
Explore a physician-led medical weight-loss program in Houston designed around individualized treatment, clinical monitoring, realistic expectations, and sustainable metabolic health.
Aevum Restorative Wellness
Your consultation is an opportunity to discuss goals, relevant medical history, prior treatment experience, concerns, and currently available options. Care is guided by laboratory findings and clinical judgment rather than a standard protocol.
Visit the clinic
Our clinic sits in Houston Heights, minutes from downtown Houston, River Oaks, Memorial, and the Texas Medical Center. Patients travel to us from across Greater Houston, and select follow-up visits are available through Aevum Mobile within our service radius.
The fastest way to start is through online booking. You can also reach the clinic by phone during business hours, or email care@aevumrestorative.com for general questions. Please do not send diagnoses, medication lists, or other sensitive medical details by email.
Medical weight-loss treatment requires individualized clinical evaluation. Not every patient is a candidate for medication. Results vary, and no specific result is guaranteed. Potential medication risks and benefits should be reviewed with a qualified clinician, and treatment may require ongoing monitoring.
Pricing may vary according to treatment plan, dose, clinical needs, medication availability, and program participation. Pricing shown on this page is current as of August 2026. Scheduling a consultation does not guarantee medication eligibility, prescribing, treatment initiation, or insurance coverage.
Retatrutide remains investigational, is not FDA approved, and is not currently offered by Aevum Restorative Wellness. Website content is educational and does not replace individualized medical advice, diagnosis, or emergency care. For a medical emergency, call 911.
Medically reviewed by Xinwei Liu, MD, Medical Director. Last reviewed July 26, 2026.
